Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Asundexian versus Apixaban in Patients with Atrial Fibrillation
Jonathan P. Piccini, Manesh R. Patel, Jan Steffel, Keith C. Ferdinand, Isabelle C. Van Gelder, Andrea M. Russo, Chang-Sheng Ma, Shaun G. Goodman, Jonas Oldgren, Christopher Hammett, Renato D. Lópes, Masaharu Akao, Raffaele De Caterina, Paulus Kirchhof, Diana A. Gorog, Martin E W Hemels, Michiel Rienstra, W. Schuyler Jones, Josephine Harrington, Professor Gregory Lip, Stephen J. Ellis, Frank W. Rockhold, Christoph Neumann, John H. Alexander, Thomas Viethen, James Hung, Rosa Coppolecchia, Hardi Mundl, Valeria Caso (2024). Asundexian versus Apixaban in Patients with Atrial Fibrillation. , 392(1), DOI: https://doi.org/10.1056/nejmoa2407105.
Article26 days agoDe-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Diana A. Gorog, José Luis Ferreiro, Ingo Ahrens, Junya Ako, Tobias Geisler, Sigrun Halvorsen, Kurt Huber, Young‐Hoon Jeong, Eliano Pio Navarese, Andrea Rubboli, Dirk Sibbing, Jolanta M. Siller‐Matula, Robert F. Storey, Jack Wei Chieh Tan, Jurriën M. ten Berg, Marco Valgimigli, Christophe Vandenbriele, Professor Gregory Lip (2023). De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. , 20(12), DOI: https://doi.org/10.1038/s41569-023-00901-2.
Article26 days agoAntithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
Ying X. Gue, Diana A. Gorog, Professor Gregory Lip (2022). Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. , 7(8), DOI: https://doi.org/10.1001/jamacardio.2022.1572.
Letter26 days agoThe East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Sungeun Park, Eun‐Seok Shin, Harry K.W. Kim, Dirk Sibbing, Professor Gregory Lip, Shanzhi Chen, Satoshi Yasuda, Wen‐Jone Chen, Myung Ho Jeong, Takeshi Kimura, Young‐Hoon Jeong, Steven C. Smith, Dominick J. Angiolillo, Shinichi Goto, Udaya S. Tantry, P.A. Gurbel, Tobias Geisler, Dae‐Soon Lim, Mónica Chan, M.H Kim, Yong Huo, Diana A. Gorog, Donggyu Park, Dániel Aradi, Zhiqian Bo (2024). The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. , DOI: https://doi.org/10.17615/c5zy-8b70.
Article26 days agoRecommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation
Geoffrey D. Barnes, Walter Ageno, Lana A. Castellucci, Thita Chiasakul, Renée Eslick, José Luis Ferreiro, David Gailani, Diana A. Gorog, Professor Gregory Lip, Leslie Raffini, Suely Meireles Rezende, Jeffrey I. Weitz, Adam Cuker (2023). Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. , 21(5), DOI: https://doi.org/10.1016/j.jtha.2023.02.008.
Article26 days ago